Mark Baldry
Corporate Officer/Principal bij X4 PHARMACEUTICALS, INC.
Vermogen: 27 900 $ op 30-04-2024
Oorsprong van het eerstegraads netwerk van Mark Baldry
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 18 | |
| Public Company | Biotechnology | 16 | |
Wave Life Sciences USA, Inc.
 Wave Life Sciences USA, Inc. Electric UtilitiesUtilities Part of Wave Life Sciences Ltd., Wave Life Sciences USA, Inc. is a company that provides nucleic acid therapeutics. The company is based in Cambridge, MA. The company was founded in 2012 by Gregory L. Verdine, Takeshi Wada. The CEO is Paul B. Bolno.
1
| Subsidiary | Electric Utilities | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Mark Baldry via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| NPS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Secretary Compliance Officer | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member | |
| AVANIR PHARMACEUTICALS INC | Pharmaceuticals: Major | Chairman Chairman Director/Board Member | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Corporate Officer/Principal | |
| INSMED INCORPORATED | Pharmaceuticals: Major | Chairman Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director of Finance/CFO Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| PTC THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Administrative Officer | |
FoldRx Pharmaceuticals LLC
 FoldRx Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology FoldRx Pharmaceuticals, Inc. provides drug discovery and clinical development services. It develops and discovers products focusing on first-in-class, disease-modifying, small molecule therapeutics to treat diseases of protein misfolding. The company was founded by Jeffery W. Kelly and Susan L. Lindquist in 2003 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| COLUCID PHARMACEUTICALS INC | Biotechnology | Director/Board Member Director/Board Member | |
| AURA BIOSCIENCES, INC. | Biotechnology | Director of Finance/CFO Chief Operating Officer | |
| ULTRAGENYX PHARMACEUTICAL INC. | Pharmaceuticals: Major | Director/Board Member | |
Scioderm, Inc.
 Scioderm, Inc. BiotechnologyHealth Technology Scioderm, Inc. engages in the development of innovative therapies for areas of high unmet need, including orphan products. The company was founded by Robert Ryan and Robert John Coull in 2012 and is headquartered in Durham, NC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| RHYTHM PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Corporate Officer/Principal | |
| BLUEBIRD BIO, INC. | Biotechnology | Director of Finance/CFO | |
The Lek/Alcar Consulting Group, Inc.
 The Lek/Alcar Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Lek/Alcar Consulting Group, Inc. provides business strategy consulting services. It offers strategy, finance, marketing and sales, operations, and transaction services including business unit strategy, brand management, pricing, alliances and joint ventures, product development, corporate transformation, and operations design. It serves the defense, energy, health, building and construction, aerospace, media, retail, and telecommunications industries. The company was founded by Andrew Kutter in 1983 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Boston College | College/University | Graduate Degree | |
| Rutgers State University of New Jersey | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree Masters Business Admin | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Utrecht | College/University | Graduate Degree | |
Catalent Pharma Solutions, Inc.
 Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Simon-Kucher & Partners GmbH
 Simon-Kucher & Partners GmbH Miscellaneous Commercial ServicesCommercial Services Simon-Kucher & Partners GmbH provides strategy, marketing and pricing services. It offers consulting services in the areas of setting and managing prices, strategic development, product and market strategy, marketing leadership, and sales execution. The firm has offices in Amsterdam, Bonn, Boston, Brussels, Cologne, Frankfurt, London, Luxembourg, Barcelona, Madrid, Milan, Moscow, Munich, New York, Paris, San Francisco, Tokyo, Vienna, Warsaw, Beijing, Singapore, Sydney and Zurich. The company was founded by Hermann Simon, Eckhard Kucher and Karl-Heinz Sebastian in 1985 and is headquartered in Bonn, Germany. | Miscellaneous Commercial Services | Director/Board Member | |
Naarden Agro Products BV
 Naarden Agro Products BV Food: Meat/Fish/DairyConsumer Non-Durables Naarden Agro Products BV engages in processing and selling caseins. It offers skimmed milk powder, full-cream milk powder, sweet whey powder, milk protein concentrates, whey protein concentrates and industrial lactic acid caseins. The company is headquartered in Nijkerk, the Netherlands. | Food: Meat/Fish/Dairy | Corporate Officer/Principal | |
| Glaxo, Inc. | Corporate Officer/Principal | ||
Genzyme Europe BV
 Genzyme Europe BV Pharmaceuticals: MajorHealth Technology Part of Sanofi, Genzyme Europe BV is a Dutch company that develops and manufactures pharmaceutical and biotherapeutic products. The company is based in Amsterdam, Netherlands. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Edimer Pharmaceuticals, Inc.
 Edimer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Edimer Pharmaceuticals, Inc. provides biopharmaceutical products for improving the health and quality of life of families living with XLHED. It has developed EDI200 as a treatment for X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), which is a rare orphan disease that causes symptoms including lack of sweat glands, poor temperature control, respiratory problems, and hair and tooth malformations. The company was founded by Pascal Schneider and Olivier Gaide in 2009 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
| GENSIGHT BIOLOGICS S.A. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| AXCA HEALPAR | Biotechnology | Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| Harvard Kennedy School of Government | College/University | Graduate Degree | |
| EPIRUS BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer | |
| Nimbas Bradford School of Management | College/University | Masters Business Admin | |
Deep Genomics, Inc.
 Deep Genomics, Inc. BiotechnologyHealth Technology Deep Genomics, Inc. provides machine learning, genome biology and precision medicine. It develops an integrated computational system that could learn, predict, and interpret how genetic variation, whether natural or therapeutic, alters crucial cellular processes. The firm offers SPIDEX database, which is a set of genetic variants and their predicted effects on human splicing across the entire genome. Its SPIDEX database covers all synonymous, missense, and nonsense exonic SNVs, as well as intronic SNVs that are up to 300nt from splice junctions. The company was founded by Brendan Frey and Hui Yuan Xiong in 2015 and is headquartered in Toronto, Canada. | Biotechnology | Chairman | |
Amicus Therapeutics UK Ltd.
 Amicus Therapeutics UK Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Amicus Therapeutics, Inc., Amicus Therapeutics UK Ltd. is a company that focuses on delivering high-quality therapies for persons living with rare and orphan diseases. The company is based in Gerrards Cross, UK. The employees of Amicus crafted a belief statement that encompasses their core values and reminds them of the reason they do what they do every day. The statement outlines the fundamental beliefs that are crucial to understanding the passion and commitment behind Amicus. The British company believes in the fight to remain at the forefront of therapies for rare and orphan diseases, supporting the disease communities and their families, and fostering teamwork and respect for each individual's contribution. | Miscellaneous Commercial Services | Director/Board Member | |
Cadena Bio, Inc.
 Cadena Bio, Inc. Pharmaceuticals: OtherHealth Technology Cadena Bio, Inc. engages in the manufacture of supplements for human health and nutrition by feeding the microbiome. The company was founded in 2016 and is headquartered in Lexington, MA. | Pharmaceuticals: Other | President | |
| 2SEVENTY BIO, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| BIOSURGERY S.R.L. | Corporate Officer/Principal | ||
| DIANTHUS THERAPEUTICS, INC. | Biotechnology | Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 34 |
| Nederland | 8 |
| Canada | 4 |
| Frankrijk | 3 |
| Duitsland | 2 |
Sectoraal
| Health Technology | 34 |
| Consumer Services | 9 |
| Commercial Services | 5 |
| Finance | 2 |
| Consumer Non-Durables | 2 |
Operationeel
| Director/Board Member | 164 |
| Corporate Officer/Principal | 88 |
| Independent Dir/Board Member | 73 |
| Chairman | 46 |
| Undergraduate Degree | 26 |
Sterkste connecties
| Insiders | |
|---|---|
| Sol Barer | 32 |
| Michael Wyzga | 31 |
| Mark Corrigan | 29 |
| Alison Lawton | 24 |
| Donald Hayden | 23 |
| Burke Whitman | 21 |
| Mike Diem | 21 |
| Gary Bridger | 16 |
| David McGirr | 16 |
| Lynn Bleil | 16 |
| Paula Ragan | 13 |
| Craig Wheeler | 12 |
| Bill Aliski | 12 |
| Adam Mostafa | 12 |
| Dipal Doshi | 12 |
- Beurs
- Insiders
- Mark Baldry
- Bedrijfsconnecties